News Read the latest news and press releases from AAX Biotech here.You can also follow us in our newsroom. Maria L Knudsen 6/2/26 Maria L Knudsen 6/2/26 AAX Biotech announces collaboration with research group at Karolinska Institutet on high-throughput characterization of novel TROP2-targeting antibodies Read More Maria Mierzejewska 5/6/26 Maria Mierzejewska 5/6/26 AAX Biotech presenting Opti-mAb poster at Antibody Engineering & Therapeutics Europe Read More Maria Mierzejewska 4/30/26 Maria Mierzejewska 4/30/26 AAX Biotech to present a poster at PEGS Boston 2026 Read More Maria L Knudsen 4/23/26 Maria L Knudsen 4/23/26 AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development Read More Maria Mierzejewska 4/22/26 Maria Mierzejewska 4/22/26 AAX Biotech pitching at KI Innovations InvestorDay 2026 Read More Guest User 3/5/26 Guest User 3/5/26 AAX Biotech to attend BIO-Europe Spring 2026 Read More Maria L Knudsen 2/19/26 Maria L Knudsen 2/19/26 AAX Biotech secures investment from Trio Impact Invest Read More Guest User 2/5/26 Guest User 2/5/26 Webinar: “The Discovery of Seqitope® and Opti-mAb® Technologies” Read More Guest User 1/29/26 Guest User 1/29/26 AAX Biotech Joins NOME Read More Guest User 1/20/26 Guest User 1/20/26 AAX Biotech announces collaboration with Vascurie to advance high-throughput antibody characterization for neuro-oncology therapies Read More Guest User 11/24/25 Guest User 11/24/25 AAX Biotech to present a poster at T-Cell Engager Therapeutics Summit Europe in London Read More Guest User 11/6/25 Guest User 11/6/25 AAX Biotech and ToxoTech Join Forces to Advance Next-Generation Biotherapeutics for Neurological Disorders Read More Guest User 10/30/25 Guest User 10/30/25 AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025 Read More Maria L Knudsen 10/28/25 Maria L Knudsen 10/28/25 AAX Biotech to present poster at PEGS Europe 2025 Read More Guest User 10/22/25 Guest User 10/22/25 AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-Generation Antibody Therapeutics Read More Guest User 10/16/25 Guest User 10/16/25 AAX Biotech to attend BIO-Europe 2025 Read More Guest User 9/29/25 Guest User 9/29/25 AAX CSO Daniel X. Johansson featured in INNOVATE™ Stockholm Read More Guest User 9/24/25 Guest User 9/24/25 AAX Biotech to attend and pitch at Nordic Life Science Days (NLSDays) 2025 Read More Guest User 9/23/25 Guest User 9/23/25 AAX featured in INNOVATE™ Stockholm Read More Guest User 9/18/25 Guest User 9/18/25 AAX Biotech to attend BioJapan 2025 (virtual) Read More Older Posts
Maria L Knudsen 6/2/26 Maria L Knudsen 6/2/26 AAX Biotech announces collaboration with research group at Karolinska Institutet on high-throughput characterization of novel TROP2-targeting antibodies Read More
Maria Mierzejewska 5/6/26 Maria Mierzejewska 5/6/26 AAX Biotech presenting Opti-mAb poster at Antibody Engineering & Therapeutics Europe Read More
Maria Mierzejewska 4/30/26 Maria Mierzejewska 4/30/26 AAX Biotech to present a poster at PEGS Boston 2026 Read More
Maria L Knudsen 4/23/26 Maria L Knudsen 4/23/26 AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development Read More
Maria Mierzejewska 4/22/26 Maria Mierzejewska 4/22/26 AAX Biotech pitching at KI Innovations InvestorDay 2026 Read More
Maria L Knudsen 2/19/26 Maria L Knudsen 2/19/26 AAX Biotech secures investment from Trio Impact Invest Read More
Guest User 2/5/26 Guest User 2/5/26 Webinar: “The Discovery of Seqitope® and Opti-mAb® Technologies” Read More
Guest User 1/20/26 Guest User 1/20/26 AAX Biotech announces collaboration with Vascurie to advance high-throughput antibody characterization for neuro-oncology therapies Read More
Guest User 11/24/25 Guest User 11/24/25 AAX Biotech to present a poster at T-Cell Engager Therapeutics Summit Europe in London Read More
Guest User 11/6/25 Guest User 11/6/25 AAX Biotech and ToxoTech Join Forces to Advance Next-Generation Biotherapeutics for Neurological Disorders Read More
Guest User 10/30/25 Guest User 10/30/25 AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025 Read More
Maria L Knudsen 10/28/25 Maria L Knudsen 10/28/25 AAX Biotech to present poster at PEGS Europe 2025 Read More
Guest User 10/22/25 Guest User 10/22/25 AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-Generation Antibody Therapeutics Read More
Guest User 9/29/25 Guest User 9/29/25 AAX CSO Daniel X. Johansson featured in INNOVATE™ Stockholm Read More
Guest User 9/24/25 Guest User 9/24/25 AAX Biotech to attend and pitch at Nordic Life Science Days (NLSDays) 2025 Read More
